Fundz

Zeno Pharma, Llc reported raising in an initial SEC Form D filing

PUBLIC · ZNTLDec 19, 2017

Round Type

Venture

San DiegoBiotechnologyHealthcareMedicalTherapeuticsPharmaceuticalresearch

Quick answer

Zentalis Pharmaceuticals raised an undisclosed amount in a funding round, dated December 19, 2017. Zentalis Pharmaceuticals is based in San Diego, California, United States.

How much did Zentalis Pharmaceuticals raise?
Zentalis Pharmaceuticals raised an undisclosed amount in a funding round on December 19, 2017.
What does Zentalis Pharmaceuticals do?
Zentalis® Pharmaceuticals, Inc. is a clinical-stage biopharmaceutical company developing azenosertib (ZN-c3), a potentially first-in-class and best-in-class WEE1 inhibitor for patients with Cyclin E1+ platinum-resistant..
Where is Zentalis Pharmaceuticals based and how big is it?
Zentalis Pharmaceuticals is based in San Diego, California, United States. Fundz records about 170 employees.
Who are the decision-makers at Zentalis Pharmaceuticals?
Fundz holds 1 contact at Zentalis Pharmaceuticals, including the Vice President, Investor Relations and Corporate Communications. Names and contact details are shown to Fundz members.

Source: Fundz verified event record.

Who else raised in Healthcare and Medical around the same time

Companies in the same sectors as Zentalis Pharmaceuticals that raised within 45 days of this round, from Fundz verified event records.

  • OnKure Therapeutics, Inc. raised $22M on January 8, 2018.
  • vTv Therapeutics Inc. raised $10M on December 19, 2017.
  • Azora Therapeutics, Inc. (DE) raised $100K on December 5, 2017.
  • Viemed Healthcare raised $2.9M (Seed) on February 1, 2018.
  • Procyrion raised $16M on January 31, 2018.
  • CUREMARK LLC raised $3.2M (Seed) on January 29, 2018.

Who to call at Zentalis Pharmaceuticals, and when

A new round usually means Zentalis Pharmaceuticals is about to hire and buy. The teams that reach out first get the meeting.

  • An alert the day Zentalis Pharmaceuticals raises, hires an executive or expands, scored against what you sell
  • The decision-makers there, with verified emails
  • Who you already know at Zentalis Pharmaceuticals, from your own LinkedIn network

Works inside ChatGPT and Claude. Ask who to call at Zentalis Pharmaceuticals. With Fundz connected, it knows.

Watch Fundz in
See plan options
Trusted byOracleSnowflakeCloudflareLinkedInGoogleSalesforce 4.8/5 on G2

Company Information

Company

Zentalis Pharmaceuticals

Location

10275 Science Center Dr

San Diego, California, United States

About

Zentalis® Pharmaceuticals, Inc. is a clinical-stage biopharmaceutical company developing azenosertib (ZN-c3), a potentially first-in-class and best-in-class WEE1 inhibitor for patients with Cyclin E1+ platinum-resistant ovarian cancer (PROC). Azenosertib is being evaluated as a monotherapy and in combination across multiple tumor types in clinical trials and has broad franchise potential. In clinical trials, azenosertib has been well tolerated and has demonstrated anti-tumor activity as a single agent across multiple tumor types. The Company is also leveraging its extensive experience and capabilities to translate its science to advance research on additional areas of opportunity for azenosertib outside PROC.

AI made execution free. Knowing first is the whole game now.

Fundz sees it the moment Zentalis Pharmaceuticals raises, hires an exec or expands, usually minutes after it happens, and tells you who to reach.

Related People

1 contact
Verified contactsAron, Vice President, Investor Relations and… hiddenSee plans and pricing
Predictive Intelligence
Strategic

ML-powered predictions for Zentalis Pharmaceuticals's next move

See what Strategic adds

Zentalis Pharmaceuticals raised. Fundz records a round at a median of 3.6 minutes from the SEC filing, with the decision-maker attached.

145 of these a day, filtered to the companies you pick, with the decision-maker attached.

5 screens from a live account. No signup.

Fundz is a real-time business intelligence platform powered by agentic AI that proactively delivers personalized daily signals, including funding rounds, executive changes, M&A activity, 13F institutional filings, SEC 8-K events, investor activity, and website modifications, based on each user's watchlist and ICP. A trusted data source at firms such as BlackRock, Oracle, Kleiner Perkins, LinkedIn, HubSpot, and Cloudflare, Fundz democratizes the institutional-grade intelligence that previously required a PitchBook or Bloomberg terminal. Features include Daily Briefing for AI-powered daily briefings, and unified cross-signal alerts across 281,000+ organizations. Developers and data teams can access these signals programmatically via the Fundz Funding Data API, with transparent published pricing.